News

Digital health company raises US$11m to advance musculoskeletal care

Published

on

The US health company Limber has announced the closing of a US$11m funding round to develop its digital musculoskeletal care platform.

Limber partners with provider groups to offer a hybrid in-person and digital approach to musculoskeletal (MSK) care through digital home exercise therapy, remote therapeutic monitoring (RTM), data analytics, and care navigation platform.

The funding round, led by Blue Venture Fund with participation from Glenview Capital, is hoped to advance and expand the company’s digital platform.

With more than half of US adults suffering from MSK pain every year, Limber aims to create more digital solutions to improve access and adherence to MSK care.

“Limber Health is proud to announce our Series A with the world-renowned healthcare investment teams at Blue Venture Fund and Glenview Capital,” said Michael Gruner, Limber co-founder and CEO.

“As MSK continues to be a leading cost driver in healthcare, we see a gap in the market for solutions driving real impact on reducing unnecessary costs.

“Both digital and in-clinic services are fundamental to maximise impact on patient outcomes and total episode costs, and we are focused on building the leading platform for delivery of hybrid MSK care. With the financing, we look forward to further enhancing our platform and growing our provider and payer partnerships.”

The company focuses on partnering with provider groups to deliver a hybrid approach to care.

Dr Emir Sandhu, who supported the funding round, said: “MSK continues to be a top focus area for payers and we are excited to partner with Limber Health to address one of the most important problems in healthcare.

“We have strong conviction in Limber’s innovative hybrid care model, which has demonstrated exceptional outcomes, and the team has built a robust network of provider partnerships nationwide.”

 

 

Click to comment

Trending stories

Exit mobile version